SpaceX Files for IPO Under Ticker SPCX Potentially Boosting Elon Musks Wealth to Trillionaire Status Beyond Inc Acquires Buy Buy Baby Brand Rights Reuniting It with Bed Bath Beyond Spacex Scrubs Starship V3 Debut Launch Retry Scheduled for Friday Home Sellers Question Commission Rates After NAR Ruling Will a 1 Million Listing Cost Less Than 6 Freightos Q1 Earnings Call Highlights Platform Strategy and Market Trends Trek 2000 Gains New Investor as Ron Sim Withdraws Legal Claims and Reduces Stake CRIS Q1 2026 Earnings DevelopmentStage Biotech Posts WiderthanExpected Loss with No Revenue VRCA Q1 2026 Earnings EPS Misses Estimates as Commercialization Costs Weigh on Results OCCI Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Market Reaction FIGS Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Movement FICO Q1 2026 Earnings EPS Surges 1165 Above Estimates Shares Rise BSAC Q1 2026 Earnings EPS Surpasses Estimates Shares Rally on Strong Performance Four Corners Property Trust FCPT Rises Slightly as Support Holds Steady Lightbridge Corporation LTBR Slips 142 as Stock Tests Key Support Near 1086 U Power Limited UCAR Tests Support After 33 Decline Key Levels in Focus Spring Valley Acquisition Corp IV Units SVIVU Hold Steady at 1026 Amid Low Volume Potential Support and Resistance Levels Define NearTerm Trading Range American Bitcoin Corp ABTC Slips 177 as BitcoinRelated Stocks Face Renewed Pressure INCR Q2 2023 Earnings EPS Beat Surprises by 287 Despite Revenue Uncertainty OPXS Q1 2026 Earnings EPS of 003 Reflects Profitability Revenue Details Not Disclosed TrueBlue Q1 2026 Earnings EPS Surprises with 979 Beat Amid Labor Market Uncertainty SFIX Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Control Progress PHAR Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower KD Q1 2026 Earnings EPS Miss Overshadowed by Strategic Optimism Barclays Delivers 18 Profit Increase Raises FullYear Income Forecast PSBD Q1 2026 Earnings Significant EPS Miss Driven by Unrealized Losses Cypherpunk Technologies CYPH Slides 8 Can Support at 101 Hold Recursion Pharmaceuticals RXRX Slips 13 as Biotech Stock Tests Key Support Near 282 Amphastar Pharmaceuticals AMPH Gains 138 as Stock Consolidates Near Key Resistance CAE Inc CAE Rallies 27 Approaching Key Resistance Amid Defense Sector Strength Syntec Optics Holdings Warrant OPTXW Slides 116 as Selling Pressure Intensifies Oriental Culture Holding OCG Bounces From Support Eyes Resistance at 192 Ryder System R Holds Steady Near 248 as Key Levels Define Trading Range NeoGenomics NEO Gains 132 Tests Key Resistance Zone Amid Sector Tailwinds